The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life, effectiveness, and compliance of fruquintinib in the treatment of metastatic colorectal cancer: Results from a prospective real-world study.
 
Jun Zhang
Employment - Johnson & Johnson/MedTech (I)
Stock and Other Ownership Interests - Johnson & Johnson/MedTech (I)
Honoraria - Bayer; Bristol-Myers Squibb; Hengrui Pharmaceutical ; Taiho Pharmaceutical; Zhengda Tianqing Pharmaceutical Group
Consulting or Advisory Role - Hengrui Pharmaceutical ; Zhengda Tianqing Pharmaceutical Group
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Hengrui Pharmaceutical ; Taiho Pharmaceutical; Zhengda Tianqing Pharmaceutical Group
Research Funding - BeiGene
 
Hong-Mei Zhang
Research Funding - Lilly O.
 
Ying-Cheng Lin
Research Funding - Lilly O.
 
Tong-Jian Cui
Research Funding - Lilly O.
 
Ying Wang
Research Funding - Lilly O.
 
Dian-Sheng Zhong
Research Funding - Lilly O.
 
Yan-ru Qin
Research Funding - Lilly O.
 
Chan Zhou
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Jin-Nan Li
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
 
Xue Zhang
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.